LONG Shengze,HUANG Shaodong,CHEN Yan,et al.Clinical effect of Cynanchi Paniculati Radix Et Rhizoma powder combined with budesonide in treatment of corticosteroid⁃responsive cough[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(04):26-30.
LONG Shengze,HUANG Shaodong,CHEN Yan,et al.Clinical effect of Cynanchi Paniculati Radix Et Rhizoma powder combined with budesonide in treatment of corticosteroid⁃responsive cough[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(04):26-30. DOI: 10.16306/j.1008-861x.2022.04.004.
Clinical effect of Cynanchi Paniculati Radix Et Rhizoma powder combined with budesonide in treatment of corticosteroid⁃responsive cough
Objective: To explore the effects of Cynanchi Paniculati Radix Et Rhizoma powder combined with budesonide in the treatment of corticosteroid-responsive cough (CRC) and its influence on the pulmonary function, inflammatory mediators in induced sputum and fractional exhaled nitric oxide (FeNO).,Methods,2,A total of 106 patients with CRC were included and randomly divided into the control group and the treatment group, 53 cases in each group. The patients in the control group were treated with budesonide aerosol through inhalation treatment, and the patients in the treatment group were orally treated with Cynanchi Paniculati Radix Et Rhizoma powder based on the treatment of the control group, with a course of 8 weeks. The clinical effect of the two groups was evaluated. The cough symptom score between the two groups was compared. The indexes of pulmonary function including forced vital capacity (FVC), forced expiratory volume in one second (FEV,1,), FEV,1,/FVC and peak expiratory flow rate (PEFR), the levels of interleukin (IL)-5 and IL-8, and eosinophil (EOS) ratio in induced sputum, and the level of FeNO were detected. The safety of the treatment was evaluated.,Results,2,①After treatment, the total clinical effective rates of the control group and the treatment group were 71.70% and 90.57% respectively, and the clinical effect of the treatment group was better than that of the control group (,P,<,0.05). ②After treatment, the cough symptom scores in the two groups were decreased compared with those before treatment (,P,<,0.05), and the score of the treatment group was lower than that of the control group (,P,<,0.05). ③After treatment, the levels of FVC, FEV,1,, FEV,1,/FVC and PEFR in the two groups were increased compared with those before treatment, and the levels of FVC, FEV,1,, FEV,1,/FVC and PEFR in the treatment group were higher than those in the control group (,P,<,0.05). ④After treatment, the levels of IL-5, IL-8 and EOS ratio in induced sputum and FeNO in the two groups were significantly decreased compared with those before treatment (,P,<,0.05), and the levels of above indexes in the treatment group were lower than those in the control group (,P,<,0.05). ⑤In the course of treatment, the incidence of adverse reaction was 24.53% in the control group and 7.55% in the treatment group, and the incidence of adverse reaction in the treatment group was lower than that in the control group (,P,<,0.05).,Conclusion,2,Cynanchi Paniculati Radix Et Rhizoma powder combined with budesonide can obviously enhance the clinical efficacy, improve the cough symptom and pulmonary function, reduce the levels of IL-5 and IL-8 and EOS ratio in induced sputum, decrease the level of FeNO, with better safety in the treatment of CRC.
关键词
激素敏感性咳嗽徐长卿散剂布地奈德肺功能诱导痰炎性递质呼出气一氧化氮
Keywords
corticosteroid-responsive coughCynanchi Paniculati Radix Et Rhizoma powderbudesonidepulmonary functioninflammatory mediators in induced sputumfractional exhaled nitric oxide
references
MORICE A H, JAKES A D, FARUQI S, et al. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response[J]. Eur Respir J, 2014, 44(5): 1149-1155.
YI F, CHEN R, LUO W, et al. Validity of Fractional Exhaled Nitric Oxide in Diagnosis of Corticosteroid-Responsive Cough[J]. Chest, 2016, 149(4): 1042-1051.
WATANABE H, SHIRAI T, AKAMATSU T, et al. Forced oscillatory parameters in reversibility testing as predictors for chronic cough responsive to inhaled corticosteroid/long-acting β2 agonist[J]. Ann Allergy Asthma Immunol, 2019, 122(3): 345-346.
FUJI S, BYRNE M, NAGLER A, et al. How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation[J]. Bone Marrow Transplant, 2021, 56(6): 1248-1256.
GAO J, WU F, WU S, et al. Inflammatory Subtypes in Classic Asthma and Cough Variant Asthma[J]. J Inflamm Res, 2020, 13: 1167-1173.
PONTICELLI C, LOCATELLI F. Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls[J]. Clin J Am Soc Nephrol, 2018, 13(5): 815-822.
XIANG J, LIU X, ZHONG S, et al. Fructus mume Protects Against Cigarette Smoke Induced Chronic Cough Guinea Pig[J]. J Med Food, 2020, 23(2): 191-197.
MATSUNAGA K, KUWAHIRA I, HANAOKA M, et al. An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice[J]. Respir Investig, 2021, 59(1): 34-52.
Effects of Qingfei Dingchuan Decoction combined with western medicine on pulmonary function, exhaled breath condensate and FeNO in patients with asthma- chronic obstructive pulmonary disease overlap syndrome
Clinical observation on Modified Liujunzi Decoction in the treatment of acute exacerbation of chronic obstructive pulmonary disease( turbid phlegm obstructing lung syndrome)
Related Author
No data
Related Institution
Department of Pulmonary Disease, Huaibei Hospital of Traditional Chinese Medicine
Department of Internal Medicine,Guangming Hospital of Traditional Chinese Medicine,Pudong New Area
Department of Internal Medicine,Kangqiao Community Health Service Center,Pudong New Area
Department of Internal Medicine,Tinglin Hospital,Jinshan District